Israeli HMO Partners with Poop Tech Startup to Launch Blood Glucose Control Service
Gut microbiome analysis startup DayTwo partnered with one of Israel’s largest health maintenance organizations
Israeli gut microbiome analysis startup DayTwo Ltd. announced Tuesday it is launching a blood glucose control service with one of Israel’s largest health maintenance organizations. As part of the deal, Clalit clients can get a DNA analysis of their gut microbiome and personalized nutritional insights based on DayTwo’s technology, as well as two online counseling sessions with Clalit dieticians.
Tel Aviv-based DayTwo was founded in 2015 and has raised $17 million to date from backers including Check Point Software Technologies Ltd. co-founder Marius Nacht—who is a DayTwo co-founder—and Israeli basketball player Omri Casspi, who last played for the NBA’s Memphis Grizzlies. The company employs 75 people, according to Pitchbook data.
A Clalit Health Services clinic. Photo: Yair Sagi